Bioactive molecules and their use in the repair of aged lead acid batteries

By constructing the Escherichia coli BL21(DE3)/pET32a-DL1 strain through genetic engineering to express the DL1 protein, the problem of lifespan and capacity decline caused by PbSO4 crystallization in aging lead-acid batteries was solved, and the batteries were repaired and their performance improved.

CN122326570APending Publication Date: 2026-07-03WUHAN RUNYUAN ENVIRONMENTAL ENERGY TECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202610450913.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-04-08
Publication Date
2026-07-03

Smart Images

  • Figure CN122326570A_ABST
    Figure CN122326570A_ABST
Patent Text Reader

Abstract

This invention discloses a bioactive molecule and its application in repairing aging lead-acid batteries, relating to the field of genetic engineering application technology. The molecule includes: a bioactive molecule DL1, whose amino acid sequence is shown in SEQ ID NO.2; a recombinant vector including the DL1 gene; a host cell including the recombinant vector; and an engineered bacterium BL21(DE3) / pET32a-DL1 constructed using genetic engineering methods. This strain can express DL1 protein intracellularly under the induction of an inducer. After purification, the DL1 protein can adsorb onto the positive and negative electrode surfaces of a lead-acid battery, altering its size by interacting with PbSO4, refining large PbSO4 particles, and increasing battery capacity, thereby achieving the purpose of repairing aging lead-acid batteries.
Need to check novelty before this filing date? Find Prior Art